Neuroleptic malignant syndrome: an easily overlooked neurologic emergency

References

• CarboneJRThe neuroleptic malignant and serotonin syndromesEmerg Med Clin North Am200018231732510767887
   PubMed Web of Science ®Google Scholar
• CaroffSNMannSCNeuroleptic malignant syndromeMed Clin North Am19937711852028093494
   PubMed Web of Science ®Google Scholar
• CaroffSNMannSCNeuroleptic malignant syndrome and malignant hyperthermiaAnaesth Intensive Care1993214477478
   Web of Science ®Google Scholar
• AdnetPLestavelPKrivosic-HorberRNeuroleptic malignant syndromeBr J Anaesth200085112913510928001
   PubMed Web of Science ®Google Scholar
• HasanSBuckleyPNovel antipsychotics and the neuroleptic malignant syndrome: a review and critiqueAm J Psychiatry19981558111311169699705
   PubMed Web of Science ®Google Scholar
• KuchibatlaSSCheemaSAChakravarthyKSSayehHGA case report of neuroleptic malignant syndromeBMJ Case Rep20092009
   Google Scholar
• PatelUAgrawalMKrishnanPNiranjanSNeuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrheaJ Natl Med Assoc200294427928211991344
   PubMed Web of Science ®Google Scholar
• AdityanjeeSajatovicMMunshiKRNeuropsychiatric sequelae of neuroleptic malignant syndromeClin Neuropharmacol200528419720416062103
   PubMed Web of Science ®Google Scholar
• Belvederi MurriMGuaglianoneABuglianiMSecond-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysisDrugs R D2015151456225578944
   PubMed Web of Science ®Google Scholar
• DelayJPichotPLemperiereTElissaldeBPeigneFUn neuroleptiques majeur non phénothiazine et non réserpine, l’halopéridol dans le traitement des psychoses. [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses]Ann Med Psychol (Paris)19601181145152 French13815606
   PubMedGoogle Scholar
• BuckleyPFHutchinsonMNeuroleptic malignant syndromeJ Neurol Neurosurg Psychiatry19955832712737897404
   PubMed Web of Science ®Google Scholar
• OtaniKHoriuchiMKondoTKanekoSFukushimaYIs the predisposition to neuroleptic malignant syndrome genetically transmitted?Br J Psychiatry19911588508531678666
   PubMed Web of Science ®Google Scholar
• ZweigYRGalvinJELewy body dementia: the impact on patients and caregiversAlzheimers Res Ther2014622125031635
   PubMed Web of Science ®Google Scholar
• PeloneroALLevensonJLPandurangiAKNeuroleptic malignant syndrome: a reviewPsychiatr Serv1998499116311729735957
   PubMed Web of Science ®Google Scholar
• HernandezJLPalacios-ArausLEchevarriaSHerranACampoJFRianchoJANeuroleptic malignant syndrome in the acquired immunodeficiency syndromePostgrad Med J1997738667797849497946
   PubMed Web of Science ®Google Scholar
• AlemanAKahnRSSeltenJPSex differences in the risk of schizophrenia: evidence from meta-analysisArch Gen Psychiatry200360656557112796219
   PubMed Web of Science ®Google Scholar
• HaackSSeeringerAThurmannPABeckerTKirchheinerJSex-specific differences in side effects of psychotropic drugs: genes or gender?Pharmacogenomics20091091511152619761372
   PubMed Web of Science ®Google Scholar
• LeungAChuePSex differences in schizophrenia, a review of the literatureActa Psychiatr Scand Suppl200040133810887978
   PubMedGoogle Scholar
• PollockBGGender differences in psychotropic drug metabolismPsychopharmacol Bull19973322352419230636
   PubMedGoogle Scholar
• ChavesACSeemanMVSex selection bias in schizophrenia antipsychotic trialsJ Clin Psychopharmacol200626548949416974190
   PubMed Web of Science ®Google Scholar
• AlexanderPJThomasRMDasAIs risk of neuroleptic malignant syndrome increased in the postpartum period?J Clin Psychiatry19985952542559632037
   PubMed Web of Science ®Google Scholar
• KeckPEJrPopeHGJrCohenBMMcElroySLNierenbergAARisk factors for neuroleptic malignant syndrome. A case-control studyArch Gen Psychiatry198946109149182572206
   PubMed Web of Science ®Google Scholar
• KhaldiSKornreichCChoubaniZGourevitchRAntipsychotiques atypiques et syndrome malin des neuroleptiques: bréve revue de la littérature. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]Encephale2008346618624 French19081460
   PubMed Web of Science ®Google Scholar
• GuptaVMagonRMishraBPSidhuGBMahajanRRisk factors in neuroleptic malignant syndromeIndian J Psychiatry2003451303521206810
   PubMedGoogle Scholar
• KeyserDLRodnitzkyRLNeuroleptic malignant syndrome in Parkinson’s disease after withdrawal or alteration of dopaminergic therapyArch Intern Med199115147947961672810
   PubMed Web of Science ®Google Scholar
• HermeshHAizenbergDWeizmanALapidotMMayorCMunitzHRisk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patientsBr J Psychiatry19921612542571355693
   PubMed Web of Science ®Google Scholar
• BerardiDAmoreMKeckPEJrTroiaMDell’AttiMClinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control studyBiol Psychiatry19984487487549798079
   PubMed Web of Science ®Google Scholar
• KochMChandragiriSRizviSPetridesGFrancisACatatonic signs in neuroleptic malignant syndromeCompr Psychiatry2000411737510646623
   PubMed Web of Science ®Google Scholar
• SawantNSKateNSBhatankarSSKulkarniPSNeuroleptic malignant syndrome in cycloserine-induced psychosisIndian J Pharmacol201547332832926069374
   PubMed Web of Science ®Google Scholar
• GuilleminGJSmithDGKerrSJCharacterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesisRedox Rep200052–310811110939285
   PubMed Web of Science ®Google Scholar
• GuilleminGJSmytheGTakikawaOBrewBJExpression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neuronsGlia2005491152315390107
   PubMed Web of Science ®Google Scholar
• FukudaKIntegrated theory to unify status among schizophrenia and manic depressive illnessMed Hypotheses201585450651126141636
   PubMed Web of Science ®Google Scholar
• NagatsuTIchinoseHRegulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterinMol Neurobiol1999191799610321973
   PubMed Web of Science ®Google Scholar
• RiddellDROwenJSNitric oxide and platelet aggregationVitam Horm199957254810232045
   PubMed Web of Science ®Google Scholar
• JendzjowskyNGJustTPJonesKEDeLoreyDSAcute tetrahydrobiopterin supplementation attenuates sympathetic vasoconstrictor responsiveness in resting and contracting skeletal muscle of healthy ratsPhysiol Rep2014210
   Google Scholar
• Vasquez-VivarJKalyanaramanBMartasekPThe role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implicationsFree Radic Res200337212112712653200
   PubMed Web of Science ®Google Scholar
• MaryKIanJTetrahydrobiopterin deficiencyNatanGHansHGOxidative Stress and Free Radical Damage in Neurology. Oxidative Stress in Applied Basic Research and Clinical PracticeNew York, NYSpringer2011225234
   Google Scholar
• BermanBDNeuroleptic malignant syndrome: a review for neurohospitalistsNeurohospitalist201111414723983836
   PubMedGoogle Scholar
• WittmannOSadotEBisker-KassifOScolnikDTavorOGlatsteinMMNeuroleptic malignant syndrome associated with metoclopramide use in a boy: case report and review of the literatureAm J Ther2016
   Web of Science ®Google Scholar
• MusselmanMESaelySDiagnosis and treatment of drug-induced hyperthermiaAm J Health Syst Pharm2013701344223261898
   PubMed Web of Science ®Google Scholar
• ChandranGJMiklerJRKeeganDLNeuroleptic malignant syndrome: case report and discussionCMAJ2003169543944212952806
   PubMed Web of Science ®Google Scholar
• StrawnJRKeckPEJrCaroffSNNeuroleptic malignant syndromeAm J Psychiatry2007164687087617541044
   PubMed Web of Science ®Google Scholar
• SeitzDPGillSSNeuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literaturePsychosomatics200950181519213967
   PubMed Web of Science ®Google Scholar
• VelamoorVRNeuroleptic malignant syndrome. Recognition, prevention and managementDrug Saf199819173829673859
   PubMed Web of Science ®Google Scholar
• GurreraRJIs neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?Clin Neuropharmacol200225418319312151905
   PubMed Web of Science ®Google Scholar
• NagelMFreisbergSJunghannsKMollCKWillenborgBDas maligne neuroleptische syndrome (NMS) – Eine systematische ϋbersicht. [The neuroleptic malignant syndrome]Fortschr Neurol Psychiatr2015837373380 German26200042
   PubMed Web of Science ®Google Scholar
• GerlachMRiedererPSchellerDMechanisms underlying and medical management of L-Dopa-associated motor complicationsJ Neural Transm2011118121659166022075781
   PubMed Web of Science ®Google Scholar
• WildEJTabriziSJThe differential diagnosis of choreaPract Neurol20077636037318024776
   PubMedGoogle Scholar
• PraharajSKJanaAKSarkarSSinhaVKOlanzapine-induced tardive oculogyric crisisJ Clin Psychopharmacol200929660460619910730
   PubMed Web of Science ®Google Scholar
• VelamoorVRNormanRMCaroffSNMannSCSullivanKAAnteloREProgression of symptoms in neuroleptic malignant syndromeJ Nerv Ment Dis199418231681737906709
   PubMed Web of Science ®Google Scholar
• LevensonJLNeuroleptic malignant syndromeAm J Psychiatry198514210113711452863986
   PubMed Web of Science ®Google Scholar
• NeuhutRLindenmayerJPSilvaRNeuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a reviewJ Child Adolesc Psychopharmacol200919441542219702493
   PubMed Web of Science ®Google Scholar
• LathamJCampbellDNicholsWMottTClinical inquiries. How much can exercise raise creatine kinase level – and does it matter?J Fam Pract200857854554718687233
   PubMed Web of Science ®Google Scholar
• ArslankoyluAEKutukMOOkuyazCTorosFNeuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticusPediatr Rep201133e1922053263
   PubMedGoogle Scholar
• HendersonVWWootenGFNeuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?Neurology19813121321376110195
   PubMed Web of Science ®Google Scholar
• Figa-TalamancaLGualandiCDi MeoLDi BattistaGNeriGLo RussoFHyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible causeNeurology19853522582613969217
   PubMed Web of Science ®Google Scholar
• SahooMKAgarwalSBiswasHCatatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatmentInd Psychiatry J201423216316525788808
   PubMedGoogle Scholar
• GragnaniACezilloMVOliveiraAFFerreiraLMNeuroleptic malignant syndrome in trauma patientBurns20154161147115126048132
   PubMed Web of Science ®Google Scholar
• NachreinerRBalleduxJZiegerMViegasOSoodRNeuroleptic malignant syndrome associated with metoclopramide in a burn patientJ Burn Care Res200627223724116566575
   PubMed Web of Science ®Google Scholar
• StillJFriedmanBLawEDeppeSEpperlyNOrletHNeuroleptic malignant syndrome in a burn patientBurns19982465735759776099
   PubMed Web of Science ®Google Scholar
• DixitSDuttaMKNamdeoMA rare case of myxedema coma with neuroleptic malignant syndrome (NMS)J Clin Diagn Res201595VD01VD03
   Google Scholar
• Al DanafJMadaraJDietscheCNeuroleptic malignant syndrome: a case aimed at raising clinical awarenessCase Rep Med2015201576957626170837
   PubMedGoogle Scholar
• MargeticBAukst-MargeticBNeuroleptic malignant syndrome and its controversiesPharmacoepidemiol Drug Saf201019542943520306454
   PubMed Web of Science ®Google Scholar
• NorthoffGCatatonia and neuroleptic malignant syndrome: psychopathology and pathophysiologyJ Neural Transm2002109121453146712486486
   PubMed Web of Science ®Google Scholar
• SachdevPSA rating scale for neuroleptic malignant syndromePsychiatry Res2005135324925615996751
   PubMed Web of Science ®Google Scholar
• HaddowAMHarrisDWilsonMLogieHClomipramine induced neuroleptic malignant syndrome and pyrexia of unknown originBMJ200432974781333133515576745
   PubMed Web of Science ®Google Scholar
• LejoyeuxMFineyreFAdesJThe serotonin syndromeAm J Psychiatry19921491014101411
   PubMed Web of Science ®Google Scholar
• SternbachHThe serotonin syndromeAm J Psychiatry199114867057132035713
   PubMed Web of Science ®Google Scholar
• CastilloERubinRTHolsboer-TrachslerEClinical differentiation between lethal catatonia and neuroleptic malignant syndromeAm J Psychiatry198914633243282645794
   PubMed Web of Science ®Google Scholar
• FleischhackerWWUnterwegerBKaneJMHinterhuberHThe neuroleptic malignant syndrome and its differentiation from lethal catatoniaActa Psychiatr Scand1990811352184638
   PubMed Web of Science ®Google Scholar
• CaroffSNMannSCKeckPEJrSpecific treatment of the neuroleptic malignant syndromeBiol Psychiatry19984463783819777166
   PubMed Web of Science ®Google Scholar
• PatelSSAllinMPPhysical complications in early clozapine treatment: a case report and implications for safe monitoringTher Adv Psychopharmacol201111252923983924
   PubMedGoogle Scholar
• BruijnzeelDSuryadevaraUTandonRAntipsychotic treatment of schizophrenia: an updateAsian J Psychiatr2014113725216917
   PubMedGoogle Scholar
• LoweCMGrubeRRScatesACCharacterization and clinical management of clozapine-induced feverAnn Pharmacother200741101700170417785616
   PubMed Web of Science ®Google Scholar
• JeongSHAhnYMKooYJKangUGKimYSThe characteristics of clozapine-induced feverSchizophr Res2002561–219119312084433
   PubMed Web of Science ®Google Scholar
• YoungCRBowersMBJrMazureCMManagement of the adverse effects of clozapineSchizophr Bull19982433813909718630
   PubMed Web of Science ®Google Scholar
• KohenIAfzalNHussainSManuPIncreases in C-reactive protein may predict recurrence of clozapine-induced feverAnn Pharmacother200943114314619126823
   PubMed Web of Science ®Google Scholar
• BrunoVValiente-GomezAAlcoverroOClozapine and fever: a case of continued therapy with clozapineClin Neuropharmacol201538415115326166236
   PubMed Web of Science ®Google Scholar
• MarmuraMJUse of dopamine antagonists in treatment of migraineCurr Treat Options Neurol2012141273522012659
   PubMed Web of Science ®Google Scholar
• ShalevAHermeshHMunitzHMortality from neuroleptic malignant syndromeJ Clin Psychiatry19895011825
   Web of Science ®Google Scholar
• GhaniSOAhmedWMarcoLANeuroleptic malignant syndrome and severe thrombocytopenia: case report and literature reviewAnn Clin Psychiatry2000121515410798826
   PubMedGoogle Scholar
• ButwickaAKrystynaSRetkaWWolanczykTNeuroleptic malignant syndrome in an adolescent with CYP2D6 deficiencyEur J Pediatr2014173121639164224253372
   PubMed Web of Science ®Google Scholar
• GuptaSRacanielloAANeuroleptic malignant syndrome associated with amoxapine and lithium in an older adultAnn Clin Psychiatry200012210710910907803
   PubMedGoogle Scholar
• ManiamTRahmanMAAll elevated creatine kinase is not neuroleptic malignant syndromeMed J Malaysia19944932522547845275
   PubMedGoogle Scholar
• VenkatasubramanianGYoganandaBHGangadharBNRisperidone-induced neuroleptic malignant syndrome: a case reportIndian J Psychiatry200042110110321407918
   PubMedGoogle Scholar
• AdityanjeeThe myth of elevated serum creatine phosphokinase level and neuroleptic malignant syndromeBr J Psychiatry19911587067071677602
   PubMed Web of Science ®Google Scholar
• HermeshHManorIShilohRHigh serum creatinine kinase level: possible risk factor for neuroleptic malignant syndromeJ Clin Psychopharmacol200222325225612006894
   PubMed Web of Science ®Google Scholar
• RosebushPStewartTA prospective analysis of 24 episodes of neuroleptic malignant syndromeAm J Psychiatry198914667177252567121
   PubMed Web of Science ®Google Scholar
• NisijimaKShiodaKA rare case of neuroleptic malignant syndrome without elevated serum creatine kinaseNeuropsychiatr Dis Treat20141040340724591835
   PubMed Web of Science ®Google Scholar
• ModiSDharaiyaDSchultzLVarelasPNeuroleptic malignant syndrome: complications, outcomes, and mortalityNeurocrit Care20162419710326223336
   PubMed Web of Science ®Google Scholar
• MackinPCardiac side effects of psychiatric drugsHum Psychopharmacol200823Suppl 131418098218
   PubMed Web of Science ®Google Scholar
• BeachSRCelanoCMNoseworthyPAJanuzziJLHuffmanJCQTc prolongation, torsades de pointes, and psychotropic medicationsPsychosomatics201354111323295003
   PubMed Web of Science ®Google Scholar
• LeuchtSCiprianiASpineliLComparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisLancet2013382989695196223810019
   PubMed Web of Science ®Google Scholar
• EiserARNeffMSSlifkinRFAcute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndromeArch Intern Med198214236016036121542
   PubMedGoogle Scholar
• LeeJWSerum iron in catatonia and neuroleptic malignant syndromeBiol Psychiatry19984464995079777183
   PubMed Web of Science ®Google Scholar
• LeeHCKimJMLimJKJoYSKimSKCentral hyperthermia treated with baclofen for patient with pontine hemorrhageAnn Rehabil Med201438226927224855623
   PubMedGoogle Scholar
• SungCYLeeTHChuNSCentral hyperthermia in acute strokeEur Neurol2009622869219521083
   PubMed Web of Science ®Google Scholar
• TakahashiYMoriHMishinaMAutoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continuaEpilepsia200546Suppl 515215815987271
   PubMed Web of Science ®Google Scholar
• LancasterEThe diagnosis and treatment of autoimmune encephalitisJ Clin Neurol201612111326754777
   PubMed Web of Science ®Google Scholar
• SplendianiAFelliVDi SibioAMagnetic resonance imaging and magnetic resonance spectroscopy in a young male patient with anti-N-methyl-D-aspartate receptor encephalitis and uncommon cerebellar involvement: a case report with review of the literatureNeuroradiol J2016291303526613928
   PubMedGoogle Scholar
• HeineJPrussHBartschTPlonerCJPaulFFinkeCImaging of autoimmune encephalitis – relevance for clinical practice and hippocampal functionNeuroscience2015309688326012492
   PubMed Web of Science ®Google Scholar
• Dhib-JalbutSHesselbrockRMouradianMMMeansEDBromocriptine treatment of neuroleptic malignant syndromeJ Clin Psychiatry198748269733804991
   PubMed Web of Science ®Google Scholar
• BonuccelliUPicciniPCorsiniGUMuratorioAApomorphine in malignant syndrome due to levodopa withdrawalItal J Neurol Sci19921321691701592579
   PubMedGoogle Scholar
• RosenbergMRGreenMNeuroleptic malignant syndrome. Review of response to therapyArch Intern Med19891499192719312673115
   PubMedGoogle Scholar
• HermeshHAizenbergDWeizmanAA successful electroconvulsive treatment of neuroleptic malignant syndromeActa Psychiatr Scand19877532372393591405
   PubMed Web of Science ®Google Scholar
• TrollorJNSachdevPSElectroconvulsive treatment of neuroleptic malignant syndrome: a review and report of casesAust N Z J Psychiatry199933565065910544988
   PubMed Web of Science ®Google Scholar
• DavisJMJanicakPGSakkasPGilmoreCWangZElectroconvulsive therapy in the treatment of the neuroleptic malignant syndromeConvuls Ther19917211112011941110
   PubMedGoogle Scholar
• MendhekarDNDuggalHSPersistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndromeJ Neuropsychiatry Clin Neurosci200618455255317135384
   PubMed Web of Science ®Google Scholar
• WuYFKanYSYangCHNeuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson’s disease – a case reportGen Hosp Psychiatry2011333301.e7e8
   Google Scholar
• SekijimaYHoshiKIKasaiHThree patients with isolated adrenocorticotropin deficiency presenting with neuroleptic malignant syndrome-like symptomsIntern Med200140651051411446676
   PubMed Web of Science ®Google Scholar
• MorigakiYIgaJKameokaNSumitaniSOhmoriTPsychiatric symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature reviewGen Hosp Psychiatry2014364449.e443e445
   Web of Science ®Google Scholar
• PopeHGJrAizleyHGKeckPEJrMcElroySLNeuroleptic malignant syndrome: long-term follow-up of 20 casesJ Clin Psychiatry19915252082121674508
   PubMed Web of Science ®Google Scholar
• CoffeyRJEdgarTSFranciscoGEAbrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndromeArch Phys Med Rehabil200283673574112048649
   PubMed Web of Science ®Google Scholar
• LuchiniFMeddaPMarianiMGMauriMToniCPerugiGElectroconvulsive therapy in catatonic patients: efficacy and predictors of responseWorld J Psychiatry20155218219226110120
   PubMed Web of Science ®Google Scholar
• OruchRElderbiMAKhattabHAPrymeIFLundALithium: a review of pharmacology, clinical uses, and toxicityEur J Pharmacol201474046447324991789
   PubMed Web of Science ®Google Scholar
• SuzukiTUchidaHWatanabeKKashimaHA potentially aborted neuroleptic malignant syndrome following seclusion against uncontrollable water intoxicationPsychopharmacol Bull200841116417018362879
   PubMedGoogle Scholar
• OruchRPrymeIFLundAThe ideal antipsychotic: hybrid between typical “haloperidol” and the atypical “colzapine” antipsychoticJ Bioanal Biomed201574124135
   Google Scholar
• OruchRLundAPrymeIFHolmsenHAn intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?J Chem Biol201032678821270935
   PubMedGoogle Scholar
• OruchRPrymeIFHolmsenHEffects of psychotropic drugs on the thrombin-induced liberation of arachidonate in human plateletsSaudi Med J200829101397140718946562
   PubMed Web of Science ®Google Scholar
• OruchRHodnelandEPrymeIFHolmsenHPsychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane?Biochim Biophys Acta20081778102165217618503745
   PubMed Web of Science ®Google Scholar
• KulkarniSKNaiduPSPathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectivesDrugs Today (Barc)2003391194912669107
   PubMed Web of Science ®Google Scholar
• KaminskaTSzuster-CiesielskaAWysockaAMarmurowska-MichalowskaHDubas-SlempHKandefer-SzerszenMSerum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neurolepticsMed Sci Monit200397CS71CS7512883457
   PubMedGoogle Scholar
• DursunSMOlubokaOJDevarajanSKutcherSPHigh-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndromeJ Psychopharmacol19981222202219694035
   PubMed Web of Science ®Google Scholar
• VermaRJunewarVRathaurBPAn atypical case of neuroleptic malignant syndrome precipitated by valproateBMJ Case Rep20142014
   Google Scholar
• TadkeRRSuryavanshiPUse of intravenous valproate in a patient with neuroleptic malignant syndromeJ Neuropsychiatry Clin Neurosci200618113113216525085
   PubMed Web of Science ®Google Scholar
• MondaMViggianoAViggianoEMessinaGTafuriDDe LucaVSympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neuronsRegul Pept20071391–3394417134769
   PubMedGoogle Scholar
• RasmussenKHsuMAYangYThe orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapyNeuropsychopharmacology200732478679217063151
   PubMed Web of Science ®Google Scholar
• MondaMViggianoAViggianoEMessinaGTafuriDDe LucaVQuetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin ANeuropeptides200640535736317010428
   PubMed Web of Science ®Google Scholar
• MondaMViggianoAMondolaROlanzapine blocks the sympathetic and hyperthermic reactions due to cerebral injection of orexin APeptides200829112012618053616
   PubMed Web of Science ®Google Scholar
• TaniiHTaniguchiNNiigawaHDevelopment of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase levelBrain Res19967431–22632709017254
   PubMed Web of Science ®Google Scholar
• SchattnerAKitroserECohenJDFatal neuroleptic malignant syndrome associated with quetiapineAm J Ther2016235e1209e121026132604
   PubMed Web of Science ®Google Scholar
• LertxundiURuizAIAspiazuMAAdverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance databaseClin Neuropharmacol2015383698425970275
   PubMed Web of Science ®Google Scholar
• HarterCObierCDruschkyKFEikelmannBMalignes neuroleptisches syndrom durch amisulprid. [Malignant neuroleptic syndrome associated with amisulpride]Nervenarzt20087918689 German17924089
   PubMed Web of Science ®Google Scholar
• YamanAKendirliTOdekCNeuroleptic malignant syndrome associated with metoclopramide in a childTurk J Pediatr201456553553726022591
   PubMed Web of Science ®Google Scholar
• MoosaviSMAhmadiMMonajemiMBAcute dystonia due to citalopram treatment: a case seriesGlob J Health Sci20146629529925363102
   PubMedGoogle Scholar
• SharonNCullenCMartinezKA complex presentation of pediatric neuroleptic malignant syndrome related to polypharmacy in a 12-year-old maleJ Child Adolesc Psychopharmacol201626657157326132089
   PubMed Web of Science ®Google Scholar
• YangYGuoYZhangANeuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidolShanghai Arch Psychiatry201426636837025642114
   PubMedGoogle Scholar